Onkos Surgical specializes in innovative solutions for musculoskeletal oncology and complex orthopedic procedures, emphasizing a personalized approach to patient care. Their flagship technologies include the ELEOS™ Limb Salvage System, which utilizes 3D printed BioGrip® Technology to enhance soft tissue attachment and reduce the risk of aseptic loosening. This system is designed to streamline surgical procedures and address the specific clinical challenges associated with limb salvage. Additionally, Onkos offers My3D® Personalized Solutions, a digital platform that facilitates tailored surgical planning and 3D visualization, ensuring that each patient's unique needs are met through customized implants and instrumentation.

The company has also made significant advancements in pediatric care with the introduction of the JTS Extendible Prosthesis, a growing implant designed for children with bone cancer. This innovative device employs magnetic technology to allow for non-invasive expansion, accommodating the natural growth of young patients while maintaining limb length equality. Onkos Surgical's commitment to enhancing patient outcomes is further supported by their new manufacturing and R&D innovation center, which aims to optimize production capabilities and deliver personalized orthopedic solutions more efficiently. With over 350 leading academic medical institutions in the U.S. utilizing their technologies, Onkos Surgical is at the forefront of redefining musculoskeletal oncology and complex orthopedic care.

United States

Onkos Surgical is a privately held, specialty medtech company founded in 2015 that uses a digital platform and patient imaging analysis, to reconstruct bones following cancer therapy using personalized surgical planning and 3D printing.

Onkos Surgical

Company Details